The dominant linear neutralizing antibody-binding site of glycoprotein gp86 of human cytomegalovirus is strain specific
about
Virion Glycoprotein-Mediated Immune Evasion by Human Cytomegalovirus: a Sticky Virus Makes a Slick GetawayIsolation of human monoclonal antibodies that potently neutralize human cytomegalovirus infection by targeting different epitopes on the gH/gL/UL128-131A complex.Cytomegalovirus reinfections in healthy seroimmune women.Strain-specific neutralization of human cytomegalovirus isolates by human sera.B cell repertoire analysis identifies new antigenic domains on glycoprotein B of human cytomegalovirus which are target of neutralizing antibodies.Human cytomegalovirus virion protein complex required for epithelial and endothelial cell tropismIdentification of glycoprotein gpTRL10 as a structural component of human cytomegalovirusGlycoprotein N of human cytomegalovirus protects the virus from neutralizing antibodies.Cytomegalovirus (CMV) genotype in allogeneic hematopoietic stem cell transplantationA novel real-time PCR method for determination and quantification of each cytomegalovirus glycoprotein H subtype in clinical samples.Human cytomegalovirus neutralizing antibody-resistant phenotype is associated with reduced expression of glycoprotein H.Scanning Mutagenesis of Human Cytomegalovirus Glycoprotein gH/gL.Glycoprotein H-related complexes of human cytomegalovirus: identification of a third protein in the gCIII complex.Characterization of a novel third member of the human cytomegalovirus glycoprotein H-glycoprotein L complex.Strain-specific neutralizing antibody responses against human cytomegalovirus envelope glycoprotein N.Vaccine-Derived Neutralizing Antibodies to the Human Cytomegalovirus gH/gL Pentamer Potently Block Primary Cytotrophoblast Infection.Neutralizing monoclonal antibodies that distinguish three antigenic sites on human cytomegalovirus glycoprotein H have conformationally distinct binding sites.Oligomerization of the human cytomegalovirus major envelope glycoprotein complex gB (gp55-116).Human cytomegalovirus gH stability and trafficking are regulated by ER-associated degradation and transmembrane architecture.Generation of potent neutralizing human monoclonal antibodies against cytomegalovirus infection from immune B cells.Enzyme-linked immunosorbent assay method for detection of cytomegalovirus strain-specific antibody responses.Functional screening for anti-CMV biologics identifies a broadly neutralizing epitope of an essential envelope proteinNeutralization of Diverse Human Cytomegalovirus Strains Conferred by Antibodies Targeting Viral gH/gL/pUL128-131 Pentameric Complex.Impact of Antibodies and Strain Polymorphisms on Cytomegalovirus Entry and Spread in Fibroblasts and Epithelial Cells.Loss of the Human Cytomegalovirus US16 Protein Abrogates Virus Entry into Endothelial and Epithelial Cells by Reducing the Virion Content of the Pentamer.The human cytomegalovirus UL74 gene encodes the third component of the glycoprotein H-glycoprotein L-containing envelope complex.Distinct glycoprotein O complexes arise in a post-Golgi compartment of cytomegalovirus-infected cells.The genes encoding the gCIII complex of human cytomegalovirus exist in highly diverse combinations in clinical isolates.Comparison of homologous and heterologous prime-boost vaccine approaches using Modified Vaccinia Ankara and soluble protein to induce neutralizing antibodies by the human cytomegalovirus pentamer complex in mice.Analysis of proteins binding to the proximal promoter region of the human cytomegalovirus IE-1/2 enhancer/promoter reveals both consensus and aberrant recognition sequences for transcription factors Sp1 and CREB.Coiled-coil domains in glycoproteins B and H are involved in human cytomegalovirus membrane fusion
P2860
Q26745798-F49EBA71-DC91-4365-8B3F-8526AA3DACFFQ33558361-2B8B8A48-60E1-4E3B-B2EC-672DA2249FEAQ33583493-EC47EE0A-9A7D-4EC1-B64F-7073DDAEE71EQ33640031-60CFB505-C823-4534-AF9C-24819D543D38Q33996614-4429305F-C185-4747-9B8B-DBC38D6AF84FQ34212879-27BC2AA6-ADED-4F5B-9B1A-8ECCD1507942Q34328645-36DF49E6-4D65-4F29-A26A-2513AB25962CQ34468958-52566C61-CF00-4DB0-BA85-8A89AC969DA3Q34809933-1BEC9241-75B8-40D2-AEF1-79D953775E7EQ35689013-B3D8AC3B-8652-493E-BC4C-808BA38FD7EFQ35847453-A847404A-15DF-4933-93F9-C9DC2105F5C9Q35866191-61F51EA2-FD7C-4A1D-80CE-0CDF8E974AD2Q35881192-EA4E67AF-0FA6-4007-B358-165A0EEE4489Q35888421-51AF094B-3622-481D-A672-A312A265483DQ36017790-6ED446C4-5E98-484B-AC21-25ACDF4DC0F6Q36281094-29A45CD0-A0B0-4EB5-987A-EE47520743D5Q36640069-C91CBCEC-52B9-4827-928F-79F07E7D3F6EQ36685373-90B2DA03-13F3-43D1-800A-9206063A7310Q36741322-A42466C4-2179-419C-BEF1-D90C0EB4130BQ37074285-8298B5A8-CFEA-4234-BF83-3EBD683B6558Q37099255-2D5761D0-71AC-4F49-AAEC-87979A9DC38BQ37519151-CD7D42D8-89DF-4088-B0BB-937557E765CCQ37707461-001E16C2-4C48-4069-89FA-242D094DE9CAQ38708710-87564A93-2587-47FC-90ED-F7D45F99EF8DQ38711117-449DE67F-50B7-4658-A43C-C7C94421914FQ39581316-4DF78203-EA28-4547-8952-7AC22D5F3076Q39682836-1718E1A6-6544-4903-8FF4-B7798B76BADCQ39685388-270357A4-228F-4C70-B842-312A35028711Q40091454-0927C9FE-07F5-4CF1-912B-7A5B6296B78FQ40422902-023B60A6-0A49-44AD-9636-43718D6D2430Q41039112-000BFB6D-F0E8-436A-98C0-498E7EE77560
P2860
The dominant linear neutralizing antibody-binding site of glycoprotein gp86 of human cytomegalovirus is strain specific
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
The dominant linear neutralizi ...... megalovirus is strain specific
@ast
The dominant linear neutralizi ...... megalovirus is strain specific
@en
type
label
The dominant linear neutralizi ...... megalovirus is strain specific
@ast
The dominant linear neutralizi ...... megalovirus is strain specific
@en
prefLabel
The dominant linear neutralizi ...... megalovirus is strain specific
@ast
The dominant linear neutralizi ...... megalovirus is strain specific
@en
P2093
P2860
P1433
P1476
The dominant linear neutralizi ...... megalovirus is strain specific
@en
P2093
P2860
P304
P407
P577
1992-03-01T00:00:00Z